Analysis of factors influencing inclusion of 102 patients with stage III/IV Hodgkin's lymphoma in a randomized trial for first-line chemotherapy.

Source:http://linkedlifedata.com/resource/pubmed/id/18552359

Download in:

View as

General Info

PMID
18552359